Regorafenib‑induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report

MLA

Yohei Funakoshi, et al. “Regorafenib‑induced Exacerbation of Chronic Immune Thrombocytopenic Purpura in Remission: A Case Report.” Molecular and Clinical Oncology, vol. 14, Dec. 2020. EBSCOhost, https://doi.org/10.3892/mco.2020.2192.

APA

Yohei Funakoshi, Yoshinori Imamura, Naomi Kiyota, Kimikazu Yakushijin, Shiro Kimbara, Hironobu Minami, Hiroshi Matsuoka, Ako Higashime, Masanori Toyoda, Yoshimi Fujishima, & Taiji Koyama. (2020). Regorafenib‑induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report. Molecular and Clinical Oncology, 14. https://doi.org/10.3892/mco.2020.2192

Chicago

Yohei Funakoshi, Yoshinori Imamura, Naomi Kiyota, Kimikazu Yakushijin, Shiro Kimbara, Hironobu Minami, Hiroshi Matsuoka, et al. 2020. “Regorafenib‑induced Exacerbation of Chronic Immune Thrombocytopenic Purpura in Remission: A Case Report.” Molecular and Clinical Oncology 14 (December). doi:10.3892/mco.2020.2192.